Kristina Kapaj
National and Kapodistrian University of Athens
Sant Joan de Déu
As a biotechnologist specializing in ATMPs and GMP, I believe that point-of-care (PoC) production is key to bringing these therapies closer to patients.
In the era of advanced therapies, treatments like CAR T cells are transforming cancer care. Yet challenges in affordability and access remain. As a biotechnologist specializing in ATMPs and GMP, I believe that point-of-care (PoC) production is key to bringing these therapies closer to patients.
In my journey as a hopper, I aim to deepen my understanding of viral vector development and GMP production in a PoC context.
I am excited to work in an international environment within a program that reinforces the importance of knowledge sharing and collaboration.”
Other Grasshoppers
We proudly partner with:
